It is also weird that he talks about the reason he raised prices at companies in the past was because it was fiduciary to shareholders. Then he starts a new com

It is also weird that he talks about the reason he raised prices at companies in the past was because it was fiduciary to shareholders. Then he starts a new company with VC money. I might be more believing if the company was a B corp. We need a different approach to drug development that is not this. The big issue with drugs is that there are only legal protections for generics and other countries have far different bargaining power. We need some kind of shared risk and reimbursement model with every country having access to the ability to buy or create generics based on them paying to support the research. This is something that could be easily spearheaded by a Gates foundation or its ilk.